Personalized medicine: A CLIA-certified high-throughput drug screening platform for ovarian cancer

被引：1
|
作者：
Swan, Hallie A. [1 ]
Rosati, Rachele [2 ]
Bridgwater, Caroline [1 ]
Churchill, Michael J. [1 ]
Watt, Roland M. [1 ]
Shaw, Reid C. [2 ]
Murphy, Stephanie A. [1 ]
Diaz, Robert L. [1 ]
Pereira, Shalini C. [1 ]
Schaub, Franz X. [1 ]
Grandori, Carla [1 ]
机构：
[1] SEngine Precis Med, Seattle, WA USA
[2] Cure First, Seattle, WA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1619
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1619
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A CLIA-CERTIFIED HIGH-THROUGHPUT DRUG SCREENING PLATFORM FOR OVARIAN CANCER TO INFORM PERSONALIZED CANCER CARE AND DISCOVER NOVEL COMBINATIONS
    Schaub, Franz X.
    Maisel, Sabrina
    Shaw, Reid
    Rosati, Rachele
    Bridgwater, Caroline
    Churchill, Michael
    Diaz, Robert
    Murphy, Stephanie Tatem
    Pereira, Shalini
    Kemp, Christopher
    Gadi, V. K.
    Grandori, Carla
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 114 - 114
  • [2] Personalization of cancer treatments with a CLIA-certified high-complexity and high-throughput drug sensitivity test
    Swan, Hallie A.
    Churchill, Michael J.
    Rosati, Rachele
    Schaub, Franz X.
    Shaw, Reid C.
    Watt, Roland M.
    Mendez, Eduardo
    Kemp, Christopher J.
    Gadi, Vijayakrishna K.
    Murphy, Stephanie A.
    Bernard, Brady
    Diaz, Robert L.
    Pereira, Shalini C.
    Grandori, Carla
    CANCER RESEARCH, 2018, 78 (13)
  • [3] A CLIA-certified functional precision medicine assay, the PARIS© test, to predict drug response for ovarian cancer
    Richardson, A.
    Dullea, A.
    Stecher, H.
    Pereira, S.
    Musa, F.
    Schaub, F. X.
    Margossian, A. L.
    Grandori, C.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 147 - 148
  • [4] Leveraging Public Cloud Services for CLIA-Certified Personalized Medicine Pipelines
    Bollig, Evan F.
    Henzler, Christine
    Lam, Ham C.
    Munro, Sarah A.
    LaRue, Rebecca
    Onsongo, Getiria
    Yohe, Sophia
    Nelson, Andrew C.
    Bower, Matthew
    Schomaker, Matthew
    Thyagarajan, Bharat
    PEARC '19: PROCEEDINGS OF THE PRACTICE AND EXPERIENCE IN ADVANCED RESEARCH COMPUTING ON RISE OF THE MACHINES (LEARNING), 2019,
  • [5] ESTABLISHMENT OF A RELIABLE GLIOBLASTOMA TUMOR-ORGANOID PLATFORM ENABLES AUTOMATED HIGH-THROUGHPUT DRUG SCREENING ADVANCING PERSONALIZED MEDICINE
    Herold-Mende, Christel
    Paul, Adrian
    Cao, Junguo
    Warta, Rolf
    Andreas, Unterberg
    Abdollahi, Amir
    Jungwirth, Gerhard
    NEURO-ONCOLOGY, 2022, 24 : 291 - 291
  • [6] High-Throughput Technologies in Personalized Medicine
    Squassina, A.
    PUBLIC HEALTH GENOMICS, 2016, 19 : 1 - 1
  • [7] High-Throughput Screening Platform for Anticancer Therapeutic Drug Cytotoxicity
    Sekhon, Bhagwant Kaur
    Roubin, Rebecca Heidi
    Tan, Aaron
    Chan, Wing Keung
    Sze, Daniel Man-Yuen
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2008, 6 (05) : 711 - 721
  • [8] Automated high-throughput image processing as part of the screening platform for personalized oncology
    Schilling, Marcel P.
    El Faraj, Razan El Khaled
    Gomez, Joaquin Eduardo Urrutia
    Sonnentag, Steffen J.
    Wang, Fei
    Nestler, Britta
    Orian-Rousseau, Veronique
    Popova, Anna A.
    Levkin, Pavel A.
    Reischl, Markus
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Automated high-throughput image processing as part of the screening platform for personalized oncology
    Marcel P. Schilling
    Razan El Khaled El Faraj
    Joaquín Eduardo Urrutia Gómez
    Steffen J. Sonnentag
    Fei Wang
    Britta Nestler
    Véronique Orian-Rousseau
    Anna A. Popova
    Pavel A. Levkin
    Markus Reischl
    Scientific Reports, 13
  • [10] Breaking barriers: A high-throughput 3D drug discovery platform for ovarian cancer
    George, Erin
    Pedro, Diego I.
    Pepe, Alfonso
    Rivera, Angie M.
    Smolchek, Ryan A.
    Famiglietti, Jack E.
    Sawyer, W. Gregory
    CANCER RESEARCH, 2024, 84 (06)
12345